{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T10:36:47Z","timestamp":1756636607072},"reference-count":72,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T00:00:00Z","timestamp":1312848000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Dev Orig Health Dis"],"published-print":{"date-parts":[[2011,10]]},"abstract":"<jats:p>Recent advances in epigenetics have enhanced our knowledge of how environmental factors (UV radiation, drugs, infections, etc.) contribute to the development of autoimmune diseases (AID) in genetically predisposed individuals. Studies conducted in monozygotic twins discordant for AID and spontaneous autoimmune animal models have highlighted the importance of DNA methylation changes and histone modifications. Alterations in the epigenetic pattern seem to be cell specific, as CD4<jats:sup>+<\/jats:sup> T cells and B cells are dysregulated in systemic lupus erythematosus, synovial fibroblasts in rheumatoid arthritis and cerebral cells in multiple sclerosis. With regard to lymphocytes, the control of tolerance is affected, leading to the development of autoreactive cells. Other epigenetic processes, such as the newly described miRNAs, and post-translational protein modifications may also be suspected. Altogether, a conceptual revolution is in progress, in AID, with potential new therapeutic strategies targeting epigenetic patterns.<\/jats:p>","DOI":"10.1017\/s2040174411000353","type":"journal-article","created":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T05:12:38Z","timestamp":1312866758000},"page":"258-264","source":"Crossref","is-referenced-by-count":16,"title":["Epigenetic alterations and autoimmune disease"],"prefix":"10.1017","volume":"2","author":[{"given":"Y.","family":"Renaudineau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Beauvillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Padelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. H.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Youinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2011,8,9]]},"reference":[{"key":"S2040174411000353_ref26","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a021898"},{"key":"S2040174411000353_ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-009-8170-x"},{"key":"S2040174411000353_ref47","first-page":"293","article-title":"Immunosuppressive effects of (2R,5R)-6-heptyne-2,5-diamine, an inhibitor of polyamine synthesis: II. Beneficial effects on the development of a lupus-like disease in MRL-lpr\/lpr mice","volume":"72","author":"Claverie","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"S2040174411000353_ref51","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02500-07"},{"key":"S2040174411000353_ref42","doi-asserted-by":"publisher","DOI":"10.1002\/art.27363"},{"key":"S2040174411000353_ref7","doi-asserted-by":"publisher","DOI":"10.1593\/neo.03490"},{"key":"S2040174411000353_ref30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-235176"},{"key":"S2040174411000353_ref24","doi-asserted-by":"publisher","DOI":"10.1177\/1352458508094641"},{"key":"S2040174411000353_ref18","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21329"},{"key":"S2040174411000353_ref22","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.622"},{"key":"S2040174411000353_ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000792"},{"key":"S2040174411000353_ref60","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.19"},{"key":"S2040174411000353_ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.12.098"},{"key":"S2040174411000353_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2005.04.002"},{"key":"S2040174411000353_ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-009-8168-4"},{"key":"S2040174411000353_ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.03.007"},{"key":"S2040174411000353_ref29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.gene.6364253","article-title":"Characterization of the human CD5 endogenous retrovirus-E in B lymphocytes","volume":"6","author":"Renaudineau","year":"2005","journal-title":"Genes Immun"},{"key":"S2040174411000353_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(91)80265-E"},{"key":"S2040174411000353_ref38","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310381517"},{"key":"S2040174411000353_ref41","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0107064"},{"key":"S2040174411000353_ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2009.12.008"},{"key":"S2040174411000353_ref11","first-page":"99","article-title":"Induction by isoniazid and hydralazine of antinuclear factors in mice","volume":"3","author":"Cannat","year":"1968","journal-title":"Clin Exp Immunol"},{"key":"S2040174411000353_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.11.012"},{"key":"S2040174411000353_ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-009-8173-7"},{"key":"S2040174411000353_ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nature08752"},{"key":"S2040174411000353_ref32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2632"},{"key":"S2040174411000353_ref2","doi-asserted-by":"publisher","DOI":"10.2217\/imt.10.49"},{"key":"S2040174411000353_ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2010.05.023"},{"key":"S2040174411000353_ref12","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830200917"},{"key":"S2040174411000353_ref67","doi-asserted-by":"publisher","DOI":"10.1002\/art.27552"},{"key":"S2040174411000353_ref25","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.3.852"},{"key":"S2040174411000353_ref36","doi-asserted-by":"publisher","DOI":"10.1038\/416865a"},{"key":"S2040174411000353_ref48","first-page":"359","article-title":"Serum free polyamines in children with systemic lupus erythmeatosus","volume":"2","author":"Puri","year":"1978","journal-title":"Adv Polyamine Res"},{"key":"S2040174411000353_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.11.018"},{"key":"S2040174411000353_ref70","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.3.2010"},{"key":"S2040174411000353_ref17","doi-asserted-by":"publisher","DOI":"10.1002\/art.25018"},{"key":"S2040174411000353_ref57","doi-asserted-by":"publisher","DOI":"10.1038\/ni1575"},{"key":"S2040174411000353_ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2007.02771.x"},{"key":"S2040174411000353_ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.11.042"},{"key":"S2040174411000353_ref16","doi-asserted-by":"publisher","DOI":"10.1101\/gr.100289.109"},{"key":"S2040174411000353_ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.02.147"},{"key":"S2040174411000353_ref20","doi-asserted-by":"publisher","DOI":"10.4161\/epi.6.1.13405"},{"key":"S2040174411000353_ref34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802412"},{"key":"S2040174411000353_ref53","first-page":"804","article-title":"Abnormal histone modification patterns in lupus CD4+ T cells","volume":"35","author":"Hu","year":"2008","journal-title":"J Rheumatol"},{"key":"S2040174411000353_ref49","first-page":"1352","article-title":"Interleukin-1beta induces elevation of spermidine\/spermine N1-acetyltransferase activity and an increase in the amount of putrescine in synovial adherent cells from patients with rheumatoid arthritis","volume":"27","author":"Furumitsu","year":"2000","journal-title":"J Rheumatol"},{"key":"S2040174411000353_ref14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0610434104"},{"key":"S2040174411000353_ref21","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320610"},{"key":"S2040174411000353_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.05.011"},{"key":"S2040174411000353_ref35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.8.5553"},{"key":"S2040174411000353_ref23","doi-asserted-by":"publisher","DOI":"10.1002\/art.23161"},{"key":"S2040174411000353_ref31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0704468104"},{"key":"S2040174411000353_ref43","first-page":"153","article-title":"Ectopic expression of activation-induced cytidine deaminase caused by epigenetics modification","volume":"25","author":"Tatemichi","year":"2011","journal-title":"Oncol Rep"},{"key":"S2040174411000353_ref58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0904060"},{"key":"S2040174411000353_ref50","first-page":"689","article-title":"Polyamine levels in synovial tissues and synovial fluids of patients with rheumatoid arthritis","volume":"19","author":"Yukioka","year":"1992","journal-title":"J Rheumatol"},{"key":"S2040174411000353_ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-009-8169-3"},{"key":"S2040174411000353_ref52","doi-asserted-by":"publisher","DOI":"10.1021\/ci700005t"},{"key":"S2040174411000353_ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.08.020"},{"key":"S2040174411000353_ref63","doi-asserted-by":"publisher","DOI":"10.1002\/art.23386"},{"key":"S2040174411000353_ref64","doi-asserted-by":"publisher","DOI":"10.1002\/art.24421"},{"key":"S2040174411000353_ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2008.04.020"},{"key":"S2040174411000353_ref61","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1481-1"},{"key":"S2040174411000353_ref62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002218"},{"key":"S2040174411000353_ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-010-9504-4"},{"key":"S2040174411000353_ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-009-8167-5"},{"key":"S2040174411000353_ref71","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0597"},{"key":"S2040174411000353_ref13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116576"},{"key":"S2040174411000353_ref68","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21329"},{"key":"S2040174411000353_ref59","doi-asserted-by":"publisher","DOI":"10.1002\/art.30196"},{"key":"S2040174411000353_ref44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.11.7422"},{"key":"S2040174411000353_ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nature08829"},{"key":"S2040174411000353_ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nature08990"},{"key":"S2040174411000353_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.12.006"}],"container-title":["Journal of Developmental Origins of Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2040174411000353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T00:31:25Z","timestamp":1556325085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2040174411000353\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,9]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S2040174411000353"],"URL":"https:\/\/doi.org\/10.1017\/s2040174411000353","relation":{},"ISSN":["2040-1744","2040-1752"],"issn-type":[{"value":"2040-1744","type":"print"},{"value":"2040-1752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,9]]}}}